ANI Pharmaceuticals, Inc. (ANIP)
NASDAQ: ANIP · IEX Real-Time Price · USD
62.19
+0.84 (1.37%)
At close: Jul 19, 2024, 4:30 PM
62.20
+0.01 (0.02%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
ANI Pharmaceuticals Market Cap
ANI Pharmaceuticals has a market cap or net worth of $1.30 billion as of July 22, 2024. Its market cap has increased by 35.57% in one year.
Market Cap
1.30B
Enterprise Value
1.35B
1-Year Change
35.57%
Ranking
Category
Stock Price
$62.19
Market Cap Chart
Since May 5, 2000, ANI Pharmaceuticals's market cap has increased from $31.10M to $1.30B, an increase of 4,091.65%. That is a compound annual growth rate of 16.68%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 1.30B | 15.74% |
Dec 29, 2023 | 1.13B | 60.39% |
Dec 30, 2022 | 702.60M | 19.57% |
Dec 31, 2021 | 587.60M | 63.72% |
Dec 31, 2020 | 358.90M | -51.87% |
Dec 31, 2019 | 745.70M | 39.70% |
Dec 31, 2018 | 533.80M | -28.93% |
Dec 29, 2017 | 751.10M | 6.89% |
Dec 30, 2016 | 702.70M | 35.42% |
Dec 31, 2015 | 518.90M | -18.78% |
Dec 31, 2014 | 638.90M | 235.20% |
Dec 31, 2013 | 190.60M | 533.22% |
Dec 31, 2012 | 30.10M | -45.47% |
Dec 30, 2011 | 55.20M | -52.74% |
Dec 31, 2010 | 116.80M | 50.13% |
Dec 31, 2009 | 77.80M | 183.94% |
Dec 31, 2008 | 27.40M | -73.32% |
Dec 31, 2007 | 102.70M | 58.73% |
Dec 29, 2006 | 64.70M | -8.62% |
Dec 30, 2005 | 70.80M | -29.83% |
Dec 31, 2004 | 100.90M | 79.86% |
Dec 31, 2003 | 56.10M | 95.47% |
Dec 31, 2002 | 28.70M | -46.55% |
Dec 31, 2001 | 53.70M | 72.12% |
Dec 29, 2000 | 31.20M | 0.32% |
View and export this data all the way back to 2000.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Disc Medicine | 1.35B |
Dynavax Technologies | 1.34B |
Nurix Therapeutics | 1.34B |
Phreesia | 1.32B |
Day One Biopharmaceuticals | 1.31B |
Arcus Biosciences | 1.30B |
Gyre Therapeutics | 1.30B |
Immatics | 1.29B |